CLB
Income statement / Annual
Last year (2023), Core Laboratories N.V.'s total revenue was $509.79 M,
an increase of 4.10% from the previous year.
In 2023, Core Laboratories N.V.'s net income was $36.68 M.
See Core Laboratories N.V.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$509.79 M
|
$489.74 M
|
$470.25 M
|
$487.27 M
|
$668.21 M
|
$700.85 M
|
$659.81 M
|
$594.74 M
|
$797.52 M
|
$1.09 B
|
| Cost of Revenue |
$415.74 M |
$410.82 M |
$386.41 M |
$395.63 M |
$518.18 M |
$520.05 M |
$499.18 M |
$469.52 M |
$560.11 M |
$691.97 M |
| Gross Profit |
$94.05 M |
$78.92 M |
$83.84 M |
$91.63 M |
$150.03 M |
$180.80 M |
$160.63 M |
$125.23 M |
$237.41 M |
$393.26 M |
| Gross Profit Ratio |
0.18 |
0.16 |
0.18 |
0.19 |
0.22 |
0.26 |
0.24 |
0.21 |
0.3 |
0.36 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$40.26 M
|
$38.12 M
|
$44.17 M
|
$34.03 M
|
$48.02 M
|
$62.91 M
|
$47.74 M
|
$39.39 M
|
$49.73 M
|
$45.66 M
|
| Selling & Marketing
Expenses |
-$1.37 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$40.26 M
|
$38.12 M
|
$44.17 M
|
$34.03 M
|
$48.02 M
|
$62.91 M
|
$47.74 M
|
$39.39 M
|
$49.73 M
|
$45.66 M
|
| Other Expenses |
$16.30 M |
-$722,000.00 |
$5.60 M |
-$1.83 M |
-$5.32 M |
$737,000.00 |
-$452,000.00 |
$344,000.00 |
-$3.67 M |
-$1.07 M |
| Operating Expenses |
$40.26 M |
$37.40 M |
$44.17 M |
$34.03 M |
$48.02 M |
$62.91 M |
$47.74 M |
$39.39 M |
$49.73 M |
$45.66 M |
| Cost And Expenses |
$455.15 M |
$448.21 M |
$430.59 M |
$429.67 M |
$566.21 M |
$582.96 M |
$546.92 M |
$508.91 M |
$609.84 M |
$737.62 M |
| Interest Income |
$0.00 |
$11.57 M |
$9.15 M |
$14.37 M |
$14.69 M |
$0.00 |
$0.00 |
$0.00 |
$56,000.00 |
$403,000.00 |
| Interest Expense |
$13.43 M |
$11.57 M |
$9.15 M |
$14.37 M |
$14.69 M |
$13.33 M |
$10.73 M |
$11.57 M |
$12.38 M |
$10.60 M |
| Depreciation &
Amortization |
$15.78 M
|
$17.16 M
|
$18.52 M
|
$20.87 M
|
$22.61 M
|
$23.09 M
|
$24.52 M
|
$26.87 M
|
$27.46 M
|
$26.70 M
|
| EBITDA |
$70.42 M
|
$58.69 M
|
$63.78 M
|
-$56.50 M
|
$119.29 M
|
$141.71 M
|
$134.49 M
|
$114.32 M
|
$188.53 M
|
$373.23 M
|
| EBITDA Ratio |
0.14 |
0.12 |
0.14 |
0.16 |
0.18 |
0.2 |
0.21 |
0.14 |
0.23 |
0.32 |
| Operating Income Ratio
|
0.11
|
0.08
|
0.1
|
0.11
|
0.14
|
0.17
|
0.17
|
0.14
|
0.2
|
0.32
|
| Total Other
Income/Expenses Net |
-$13.43 M
|
-$11.57 M
|
-$9.15 M
|
-$14.37 M
|
-$14.69 M
|
-$13.33 M
|
-$8.26 M
|
-$11.57 M
|
-$12.38 M
|
-$10.60 M
|
| Income Before Tax |
$41.21 M |
$29.95 M |
$36.11 M |
-$91.18 M |
$81.99 M |
$105.29 M |
$101.71 M |
$74.61 M |
$148.69 M |
$335.93 M |
| Income Before Tax Ratio
|
0.08
|
0.06
|
0.08
|
-0.19
|
0.12
|
0.15
|
0.15
|
0.13
|
0.19
|
0.31
|
| Income Tax Expense |
$4.19 M |
$10.30 M |
$15.89 M |
$5.90 M |
-$12.29 M |
$25.45 M |
$18.61 M |
$10.75 M |
$33.76 M |
$77.31 M |
| Net Income |
$36.68 M |
$19.45 M |
$19.73 M |
-$97.07 M |
$101.98 M |
$79.53 M |
$83.13 M |
$63.90 M |
$114.85 M |
$257.49 M |
| Net Income Ratio |
0.07 |
0.04 |
0.04 |
-0.2 |
0.15 |
0.11 |
0.13 |
0.11 |
0.14 |
0.24 |
| EPS |
0.79 |
0.42 |
0.51 |
-2.18 |
2.11 |
1.8 |
1.88 |
1.45 |
2.71 |
5.9 |
| EPS Diluted |
0.77 |
0.42 |
0.5 |
-2.16 |
2.1 |
1.79 |
1.88 |
1.45 |
2.68 |
5.77 |
| Weighted Average Shares
Out |
$46.68 M
|
$46.33 M
|
$46.01 M
|
$44.48 M
|
$44.36 M
|
$44.21 M
|
$44.15 M
|
$43.48 M
|
$42.38 M
|
$43.64 M
|
| Weighted Average Shares
Out Diluted |
$47.52 M
|
$46.81 M
|
$46.69 M
|
$44.97 M
|
$44.65 M
|
$44.47 M
|
$44.26 M
|
$44.15 M
|
$42.91 M
|
$44.60 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
